Clayton A - Search Results

1

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.

Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Clayton A, et al. J Sex Med. 2007 Jul;4(4 Pt 1):917-29. doi: 10.1111/j.1743-6109.2007.00520.x. J Sex Med. 2007. PMID: 17627739 Clinical Trial.

2

Assessment of paroxetine-induced sexual dysfunction using the Changes in Sexual Functioning Questionnaire.

Clayton AH, Owens JE, McGarvey EL. Clayton AH, et al. Psychopharmacol Bull. 1995;31(2):397-413. Psychopharmacol Bull. 1995. PMID: 7491398 Clinical Trial.

3

The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity.

Clayton AH, McGarvey EL, Clavet GJ. Clayton AH, et al. Psychopharmacol Bull. 1997;33(4):731-45. Psychopharmacol Bull. 1997. PMID: 9493486

4

Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ).

Clayton AH, McGarvey EL, Clavet GJ, Piazza L. Clayton AH, et al. Psychopharmacol Bull. 1997;33(4):747-53. Psychopharmacol Bull. 1997. PMID: 9493487

5

Recognition and assessment of sexual dysfunction associated with depression.

Clayton AH. Clayton AH. J Clin Psychiatry. 2001;62 Suppl 3:5-9. J Clin Psychiatry. 2001. PMID: 11229452 Review.

6

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC. Clayton AH, et al. J Clin Psychiatry. 2001 Mar;62(3):185-90. doi: 10.4088/jcp.v62n0309. J Clin Psychiatry. 2001. PMID: 11305705

7

Prevalence of sexual dysfunction among newer antidepressants.

Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A. Clayton AH, et al. J Clin Psychiatry. 2002 Apr;63(4):357-66. doi: 10.4088/jcp.v63n0414. J Clin Psychiatry. 2002. PMID: 12000211

8

Female sexual dysfunction related to depression and antidepressant medications.

Clayton AH. Clayton AH. Curr Womens Health Rep. 2002 Jun;2(3):182-7. Curr Womens Health Rep. 2002. PMID: 12099193 Review.

9

Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.

Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE. Clayton AH, et al. Int Clin Psychopharmacol. 2003 May;18(3):151-6. doi: 10.1097/01.yic.0000066456.73432.09. Int Clin Psychopharmacol. 2003. PMID: 12702894 Clinical Trial.

10

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction.

Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. Clayton AH, et al. J Clin Psychiatry. 2004 Jan;65(1):62-7. doi: 10.4088/jcp.v65n0110. J Clin Psychiatry. 2004. PMID: 14744170 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

735 results

Search Page

Filters